World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
63
Citations
19653
World Ranking
1784
National Ranking
124

Michael Rehli publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Michael Rehli sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 151 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Michael Rehli D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Rehli sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 63 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Michael Rehli is affiliated with the University of Regensburg in Germany. Their research primarily spans the fields of Immunology and Microbiology, Biochemistry, Genetics and Molecular Biology, and Medicine. Within these broader fields, their work focuses on subfields such as Immunology, Molecular Biology, Hematology, Genetics, and Oncology.

The scientist's research covers multiple main topics including Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Epigenetics and DNA Methylation, CAR-T cell therapy research, Genomics and Chromatin Dynamics, and Hematopoietic Stem Cell Transplantation.

Frequent collaborators in their research include Claudia Gebhard, Petra Hoffmann, Nicholas Strieder, Wolfgang Herr, and Christian Schmidl. These coauthors have contributed substantially to various projects alongside Michael Rehli.

Their frequent publication venues reflect the scope and impact of their research. These include Nature Communications, bioRxiv (Cold Spring Harbor Laboratory), Blood, Immunity, and Proceedings of the National Academy of Sciences.

Selected recent papers authored or co-authored by Michael Rehli include:

  • Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF, 2020, Immunity
  • Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells, 2021, Immunity
  • Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1, 2020, Nature Communications
  • Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy, 2024, Cell
  • The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites, 2021, Nature Communications

Best Publications

  • An atlas of active enhancers across human cell types and tissues

    Robin Andersson;Claudia Gebhard;Irene Miguel-Escalada;Ilka Hoof

  • A promoter-level mammalian expression atlas

    Alistair R.R. Forrest;Hideya Kawaji;Michael Rehli;J. Kenneth Baillie

  • Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

    Alexzander Asea;Michael Rehli;Edith Kabingu;Jason A. Boch

  • Gateways to the FANTOM5 promoter level mammalian expression atlas

    Marina Lizio;Jayson Harshbarger;Hisashi Shimoji;Jessica Severin

  • An integrated expression atlas of miRNAs and their promoters in human and mouse.

    Derek De Rie;Imad Abugessaisa;Tanvir Alam;Erik Arner

  • The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line

    Harukazu Suzuki;Alistair R.R. Forrest;Erik Van Nimwegen;Carsten O. Daub

  • Of mice and men: species variations of Toll-like receptor expression.

    Michael Rehli

  • Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation

    M. Rehli;S. W. Krause;Reinhard Andreesen

  • FANTOM5 CAGE profiles of human and mouse samples

    Shuhei Noguchi;Takahiro Arakawa;Shiro Fukuda;Masaaki Furuno

  • Expression of CD68 in Non-Myeloid Cell Types

    E. Gottfried;L. A. Kunz-Schughart;A. Weber;M. Rehli

  • Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.

    Christian Schmidl;Maja Klug;Tina J. Boeld;Reinhard Andreesen

  • PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene

    Michael Rehli;Alexander Poltorak;Lucia Schwarzfischer;Stefan W. Krause

  • miRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma

    Daniel W. Mueller;Michael Rehli;Anja K. Bosserhoff

  • Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector.

    Maja Klug;Michael Rehli

  • Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation.

    Michael Rehli;Hans Helmut Niller;Christoph Ammon;Sabine Langmann

  • Species-specific Regulation of Toll-like Receptor 3 Genes in Men and Mice

    Sven Heinz;Viola Haehnel;Marina Karaghiosoff;Lucia Schwarzfischer

  • DIFFERENTIAL SCREENING IDENTIFIES GENETIC MARKERS OF MONOCYTE TO MACROPHAGE MATURATION

    Stefan W. Krause;Michael Rehli;Marina Kreutz;Lucia Schwarzfischer

  • Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia

    Claudia Gebhard;Lucia Schwarzfischer;Thu-Hang Pham;Elmar Schilling

  • Transcriptional Regulation of the Human Toll-Like Receptor 2 Gene in Monocytes and Macrophages

    Viola Haehnel;Lucia Schwarzfischer;Matthew J. Fenton;Michael Rehli

  • Transcription and enhancer profiling in human monocyte subsets

    Christian Schmidl;Kathrin Renner;Katrin Peter;Ruediger Eder

Frequent Co-Authors

Reinhard Andreesen
Reinhard Andreesen University of Regensburg
David A. Hume
David A. Hume University of Queensland
Matthias Edinger
Matthias Edinger University of Regensburg
Alistair R. R. Forrest
Alistair R. R. Forrest Harry Perkins Institute of Medical Research
Timo Lassmann
Timo Lassmann Telethon Kids Institute
Christine A. Wells
Christine A. Wells University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Molecular Biology opens doors to a variety of healthcare and research professions. Many students consider related fields—such as nursing and advanced practice—where biological expertise is essential. If you’re interested in patient care or specialized nursing roles, it can be helpful to understand how many years to become a nurse practitioner. This pathway requires a solid foundation in biology as well as advanced clinical training.

For current registered nurses aiming to advance quickly, there are flexible options like rn to bsn online degree programs. These allow RNs to earn a Bachelor of Science in Nursing efficiently—an important step for many career advancements. Others may prefer transitioning from an associate degree; asn to np programs provide accelerated tracks leading directly from RN credentials to Nurse Practitioner status.

Non-nursing graduates with a background in molecular biology or other sciences can also pursue advanced degrees through direct entry msn programs. These intensive online programs enable students from diverse educational backgrounds to enter the nursing field and specialize in roles that blend biological sciences with patient care.

Best Scientists Citing Michael Rehli

Trending Scientists

Recently Published Articles